Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Gilead Sciences Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable 1.21 1.38 1.04 1.31 1.41 1.66 1.00 1.10 0.89 0.94 1.00 1.01 1.43 0.98 0.90 0.92 1.04 0.87 0.89 0.84
Accrued rebates 7.35 8.42 7.56 7.42 6.60 7.54 7.32 7.57 6.12 5.95 5.61 5.62 5.51 5.87 5.60 5.47 4.77 5.02 4.84 4.99
Current portion of long-term debt, net 4.76 4.79 5.04 4.97 3.08 3.32 3.38 6.51 2.89 2.87 6.48 3.69 3.60 3.63 1.62 1.62 2.23 3.74 3.33 3.35
Other current liabilities 6.70 6.41 6.44 8.18 9.26 8.98 8.42 7.93 8.26 9.38 9.32 6.69 7.25 6.18 6.55 5.55 9.04 5.64 5.96 5.20
Current liabilities 20.01% 21.01% 20.08% 21.87% 20.35% 21.50% 20.12% 23.12% 18.16% 19.15% 22.40% 17.01% 17.79% 16.66% 14.67% 13.57% 17.09% 15.27% 15.02% 14.38%
Long-term debt, net, excluding current portion 37.49 37.82 39.73 39.24 42.20 39.32 40.20 38.24 37.33 37.18 34.02 37.10 36.34 36.69 40.07 39.92 37.05 37.52 41.06 41.35
Long-term income taxes payable 1.52 1.48 1.54 1.45 1.41 1.43 1.38 3.49 3.28 3.35 4.19 6.10 6.20 6.37 6.18 7.60 7.02 6.92 6.76 7.44
Deferred tax liability 0.68 1.02 1.17 1.26 1.23 1.46 1.69 1.66 2.56 3.18 3.38 3.88 4.23 4.85 5.35 5.84 6.41 6.86 6.43 6.61
Other long-term obligations 1.97 2.02 2.32 2.37 2.20 2.56 2.64 2.48 2.06 1.48 2.17 2.06 1.87 1.77 1.57 1.50 1.44 1.43 1.73 2.12
Long-term liabilities 41.67% 42.33% 44.76% 44.32% 47.03% 44.77% 45.92% 45.87% 45.22% 45.19% 43.76% 49.15% 48.64% 49.68% 53.18% 54.86% 51.92% 52.73% 55.98% 57.52%
Total liabilities 61.68% 63.34% 64.84% 66.19% 67.38% 66.27% 66.04% 68.99% 63.38% 64.34% 66.16% 66.16% 66.43% 66.34% 67.85% 68.43% 69.00% 68.00% 71.01% 71.90%
Preferred stock, par value $0.001 per share; none outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, par value $0.001 per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 15.13 14.83 15.02 14.42 13.05 13.44 13.11 12.10 10.46 10.07 9.64 9.36 8.79 8.35 8.00 7.72 6.86 6.69 6.28 6.06
Accumulated other comprehensive income (loss) 0.07 0.06 -0.03 0.16 0.22 0.13 0.17 0.12 0.05 0.05 0.02 -0.03 0.00 0.16 0.14 0.12 0.12 0.11 0.06 0.06
Retained earnings 23.26 21.91 20.32 19.37 19.49 20.31 20.84 18.93 26.24 25.66 24.29 24.60 24.83 25.19 24.04 23.76 24.02 25.19 22.64 21.96
Total Gilead stockholders’ equity 38.46% 36.80% 35.31% 33.95% 32.77% 33.88% 34.12% 31.16% 36.75% 35.78% 33.94% 33.93% 33.62% 33.70% 32.19% 31.59% 31.01% 32.00% 28.98% 28.08%
Noncontrolling interest -0.14 -0.14 -0.15 -0.15 -0.14 -0.16 -0.16 -0.15 -0.14 -0.12 -0.10 -0.09 -0.05 -0.04 -0.03 -0.02 -0.01 0.00 0.01 0.02
Total stockholders’ equity 38.32% 36.66% 35.16% 33.81% 32.62% 33.73% 33.96% 31.01% 36.62% 35.66% 33.84% 33.84% 33.57% 33.66% 32.15% 31.57% 31.00% 32.00% 28.99% 28.10%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The composition of liabilities and stockholders’ equity exhibited several notable trends over the observed period from March 2021 to December 2025. Overall, total liabilities generally remained relatively stable, fluctuating between approximately 66% and 72% of the total, while stockholders’ equity accounted for the remaining portion. Within these broad categories, specific line items demonstrated more pronounced shifts.

Current Liabilities
Current liabilities as a percentage of the total experienced an increase from 14.38% in March 2021 to a peak of 23.12% in March 2023, before decreasing to 20.01% by December 2025. This increase was largely driven by fluctuations in ‘Other current liabilities’ and ‘Current portion of long-term debt, net’. ‘Other current liabilities’ increased significantly, peaking at 9.38% in June 2023, and then declining. ‘Current portion of long-term debt, net’ showed considerable volatility, rising from 3.35% to 6.48% between March 2021 and June 2022, then decreasing before increasing again to 4.97% in March 2025.
Long-Term Liabilities
Long-term liabilities demonstrated a decreasing trend from 57.52% in March 2021 to a low of 48.64% in December 2022, before increasing to 41.67% by December 2025. This movement was primarily influenced by ‘Long-term debt, net, excluding current portion’, which decreased from 41.35% to 34.02% over the same period. ‘Long-term income taxes payable’ and ‘Deferred tax liability’ both exhibited consistent declines throughout the period, contributing to the overall reduction in long-term liabilities.
Stockholders’ Equity Components
Within stockholders’ equity, ‘Retained earnings’ consistently represented a significant portion, fluctuating between approximately 21.96% and 26.24%. ‘Additional paid-in capital’ showed a steady increase from 6.06% in March 2021 to 15.13% in September 2025. ‘Accumulated other comprehensive income (loss)’ remained relatively small, with minor fluctuations, and became negative in later periods. The ‘Common stock’ and ‘Preferred stock’ components remained consistently at zero throughout the observed timeframe.
Accounts Payable and Accrued Rebates
‘Accounts payable’ showed a general increasing trend, rising from 0.84% to 1.21% between March 2021 and September 2025, before decreasing to 1.04% by December 2025. ‘Accrued rebates’ remained a substantial component of current liabilities, fluctuating between approximately 4.77% and 8.42%, with a peak in September 2025. This suggests a potential correlation with revenue recognition policies or sales patterns.

In summary, the liability structure shifted towards a greater proportion of current liabilities, particularly driven by ‘Other current liabilities’ and ‘Current portion of long-term debt, net’, while long-term debt decreased. Stockholders’ equity experienced growth in ‘Additional paid-in capital’ and ‘Retained earnings’, contributing to a relatively stable overall equity position. These changes suggest a dynamic financial landscape requiring continued monitoring.

AI Ask an analyst for more